<p>Squarepoint Ops LLC 在最近向證券交易委員會（SEC）提交的 13F 文件中表示，在第二季度將其在布魯克公司（NASDAQ:BRKR - 免費報告）股票中的持股比例減少了 42.7%。該機構投資者在此期間出售了 77,226 股後，持有 103,501 股該醫療研究公司的股票。Squarepoint Ops LLC 在最近一個季度末持有的布魯克股份約佔 0.07%，價值 4,264,000 美元。</p>
<p>其他幾家對沖基金和機構投資者最近也調整了對該股票的持有。Nisa Investment Advisors LLC 在第二季度將其在布魯克的持股比例提高了 377.5%。Nisa Investment Advisors LLC 目前持有 616 股該醫療研究公司的股票，價值 25,000 美元，此前在上個季度又購買了 487 股。亨廷頓國家銀行在第二季度將其在布魯克的持股比例提高了 750.0%。亨廷頓國家銀行目前持有 731 股該醫療研究公司的股票，價值 30,000 美元，此前在上個季度又購買了 645 股。Spire Wealth Management 在第二季度獲得了布魯克的新頭寸，價值約 32,000 美元。凱通國際資產管理有限公司在第一季度將其在布魯克的持股比例提高了 1,354.5%。凱通國際資產管理有限公司目前持有 800 股該醫療研究公司的股票，價值 33,000 美元，此前在上個季度又購買了 745 股。最後，Parallel Advisors LLC 在第二季度將其在布魯克的持股比例提高了 63.0%。Parallel Advisors LLC 目前持有 898 股該醫療研究公司的股票，價值 37,000 美元，此前在上個季度又購買了 347 股。機構投資者持有該公司 79.52% 的股票。</p>
<h2>分析師評級調整</h2>
<p>布魯克的股票曾受到多份研究報告的關注。TD Cowen 在 11 月 4 日的報告中將布魯克的目標價格從 40.00 美元上調至 42.00 美元，並給予該股票 &#34;持有&#34; 評級。摩根大通在週一將布魯克的目標價格從 50.00 美元上調至 55.00 美元，並給予該股票 &#34;增持&#34; 評級。高盛集團在 12 月 9 日的研究報告中開始覆蓋布魯克股票，設定了 &#34;賣出&#34; 評級和 40.00 美元的目標價格。Redburn Partners 在 11 月 20 日的研究報告中設定了布魯克的目標價格為 60.00 美元。最後，瑞銀集團在 11 月 4 日的研究報告中將布魯克的目標價格從 40.00 美元上調至 43.00 美元，並給予該公司 &#34;中性&#34; 評級。一位股票研究分析師給予該股票 &#34;強烈買入&#34; 評級，八位分析師給予 &#34;買入&#34; 評級，六位分析師給予 &#34;持有&#34; 評級，二位分析師給予 &#34;賣出&#34; 評級。根據 MarketBeat 的數據，布魯克的共識評級為 &#34;持有&#34;，平均目標價格為 52.86 美元。</p>
<p><strong>閲讀我們關於布魯克的最新股票分析</strong></p>
<h2>布魯克股票上漲 1.2%</h2>
<p>NASDAQ:BRKR 的股票在週二開盤價為 45.67 美元。布魯克公司的 52 周低點為 28.53 美元，52 周高點為 64.64 美元。該公司的速動比率為 0.91，流動比率為 1.85，債務股本比率為 0.81。該公司的市值為 69.4 億美元，市盈率為 -285.44，市盈率/增長比率為 6.64，貝塔值為 1.17。該公司的 50 日移動平均價格為 41.86 美元，200 日移動平均價格為 38.39 美元。</p>
<p>布魯克（NASDAQ:BRKR - 獲取免費報告）最近在 11 月 3 日宣佈了其季度財報。該醫療研究公司報告的季度每股收益為 0.45 美元，超出市場共識預期的 0.33 美元，超出幅度為 0.12 美元。該季度的收入為 8.605 億美元，而分析師預期為 8.474 億美元。布魯克的淨利潤率為 -0.61%，股本回報率為 15.45%。與去年同期相比，布魯克的收入下降了 0.5%。去年同期，該公司每股收益為 0.60 美元。布魯克已將其 2025 財年的指導目標設定為 1.850-1.90 每股收益。賣方分析師預計布魯克公司今年的每股收益將達到 2.69 美元。</p>
<h2>布魯克分紅公告</h2>
<p>該公司最近還宣佈了一項季度分紅，將於 1 月 2 日（星期五）支付。12 月 8 日的股東將獲得每股 0.05 美元的分紅。這相當於每年 0.20 美元的分紅，收益率為 0.4%。除息日期為 12 月 8 日。布魯克的派息比率為 -125.00%。</p>
<h2>內部交易活動</h2>
<p>在其他新聞中，董事 John A. Ornell 於 11 月 6 日在一筆交易中出售了 6,233 股該公司的股票。該股票以平均價格 39.00 美元出售，總交易額為 243,087.00 美元。交易後，該董事直接持有該公司 35,212 股股票，價值約 1,373,268 美元。這筆交易代表了其持股比例的 15.04% 的減少。該出售在向證券交易委員會提交的文件中披露，文件可通過 SEC 網站訪問。內部人士持有該公司 27.30% 的股票。</p>
<h2>布魯克公司簡介</h2>
<p>（免費報告）</p>
<p>布魯克公司及其子公司在美國、歐洲、亞太地區及國際上開發、製造和分銷科學儀器以及分析和診斷解決方案。該公司通過四個部門運營：布魯克科學儀器（BSI）生物旋轉、BSI CALID、BSI 納米和布魯克能源與超導技術。</p>
<h2>特色文章</h2>
<ul>
<li>五隻我們認為比布魯克更好的股票</li>
<li>最佳股息貴族名單：通過貴族指數積累財富</li>
<li>ServiceNow 的 70 億美元賭注：恐慌還是機會？</li>
<li>什麼是股息收割策略，投資者如何從中獲利？</li>
<li>戴爾和惠普正在提價——投資者應該注意</li>
<li>房地產投資信託是否應在您的投資組合中佔有一席之地？</li>
<li>為什麼 DLocal 是 2026 年值得關注的頂級新興市場金融科技股票</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9QlJLUg?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9QlJLUg"/></p>
<p><em>此即時新聞提醒由敍事科學技術和 MarketBeat 的金融數據生成，旨在為讀者提供最快的報道和公正的覆蓋。請將任何問題或意見發送至 contact@marketbeat.com。</em></p>
<h2>您現在應該投資 1,000 美元在布魯克嗎？</h2>
<p>在您考慮布魯克之前，您需要聽聽這個。</p>
<p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已識別出五隻頂級分析師悄悄向客户推薦的股票，建議在更廣泛的市場注意到之前購買……而布魯克並不在名單上。</p>
<p>雖然布魯克目前在分析師中被評為持有評級，但頂級分析師認為這五隻股票更值得購買。</p>
<p>在這裏查看這五隻股票</p>

布魯克

<p>Squarepoint Ops LLC 在第二季度減少了對布魯克公司的持股，降幅為 42.7%，目前持有 103,501 股，價值 426 萬美元。其他機構投資者也調整了他們的持股，有些則增加了持股比例。分析師對布魯克的評級意見不一，普遍維持 “持有” 評級，平均目標價為 52.86 美元。布魯克的股票開盤價為 45.67 美元，52 周價格區間為 28.53 美元至 64.64 美元。該公司報告第三季度每股收益為 0.45 美元，超出預期，並宣佈季度股息為每股 0.05 美元</p>

<p>Squarepoint Ops LLC reduced its stake in shares of Bruker Corporation (NASDAQ:BRKR - Free Report) by 42.7% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 103,501 shares of the medical research company's stock after selling 77,226 shares during the period. Squarepoint Ops LLC owned about 0.07% of Bruker worth $4,264,000 at the end of the most recent quarter.</p>
<div class="lb-trans"><p>Squarepoint Ops LLC 在最近向證券交易委員會（SEC）提交的 13F 文件中表示，在第二季度將其在布魯克公司（NASDAQ:BRKR - 免費報告）股票中的持股比例減少了 42.7%。該機構投資者在此期間出售了 77,226 股後，持有 103,501 股該醫療研究公司的股票。Squarepoint Ops LLC 在最近一個季度末持有的布魯克股份約佔 0.07%，價值 4,264,000 美元。</p>
</div><p>Several other hedge funds and other institutional investors also recently modified their holdings of the stock. Nisa Investment Advisors LLC raised its stake in shares of Bruker by 377.5% in the 2nd quarter. Nisa Investment Advisors LLC now owns 616 shares of the medical research company's stock valued at $25,000 after purchasing an additional 487 shares in the last quarter. Huntington National Bank lifted its holdings in Bruker by 750.0% during the 2nd quarter. Huntington National Bank now owns 731 shares of the medical research company's stock worth $30,000 after buying an additional 645 shares during the last quarter. Spire Wealth Management acquired a new position in shares of Bruker in the 2nd quarter worth approximately $32,000. Caitong International Asset Management Co. Ltd increased its holdings in shares of Bruker by 1,354.5% in the 1st quarter. Caitong International Asset Management Co. Ltd now owns 800 shares of the medical research company's stock valued at $33,000 after acquiring an additional 745 shares during the last quarter. Finally, Parallel Advisors LLC raised its position in shares of Bruker by 63.0% during the 2nd quarter. Parallel Advisors LLC now owns 898 shares of the medical research company's stock valued at $37,000 after acquiring an additional 347 shares in the last quarter. Institutional investors own 79.52% of the company's stock.</p>
<div class="lb-trans"><p>其他幾家對沖基金和機構投資者最近也調整了對該股票的持有。Nisa Investment Advisors LLC 在第二季度將其在布魯克的持股比例提高了 377.5%。Nisa Investment Advisors LLC 目前持有 616 股該醫療研究公司的股票，價值 25,000 美元，此前在上個季度又購買了 487 股。亨廷頓國家銀行在第二季度將其在布魯克的持股比例提高了 750.0%。亨廷頓國家銀行目前持有 731 股該醫療研究公司的股票，價值 30,000 美元，此前在上個季度又購買了 645 股。Spire Wealth Management 在第二季度獲得了布魯克的新頭寸，價值約 32,000 美元。凱通國際資產管理有限公司在第一季度將其在布魯克的持股比例提高了 1,354.5%。凱通國際資產管理有限公司目前持有 800 股該醫療研究公司的股票，價值 33,000 美元，此前在上個季度又購買了 745 股。最後，Parallel Advisors LLC 在第二季度將其在布魯克的持股比例提高了 63.0%。Parallel Advisors LLC 目前持有 898 股該醫療研究公司的股票，價值 37,000 美元，此前在上個季度又購買了 347 股。機構投資者持有該公司 79.52% 的股票。</p>
</div><h2>Analyst Upgrades and Downgrades</h2>
<div class="lb-trans"><h2>分析師評級調整</h2>
</div><p>BRKR has been the subject of a number of research reports. TD Cowen lifted their price objective on shares of Bruker from $40.00 to $42.00 and gave the stock a &#34;hold&#34; rating in a report on Tuesday, November 4th. JPMorgan Chase &amp; Co. raised their price target on shares of Bruker from $50.00 to $55.00 and gave the stock an &#34;overweight&#34; rating in a research report on Monday. The Goldman Sachs Group initiated coverage on shares of Bruker in a research report on Tuesday, December 9th. They set a &#34;sell&#34; rating and a $40.00 price objective for the company. Redburn Partners set a $60.00 price objective on shares of Bruker in a research note on Thursday, November 20th. Finally, UBS Group lifted their target price on Bruker from $40.00 to $43.00 and gave the company a &#34;neutral&#34; rating in a research note on Tuesday, November 4th. One equities research analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating, six have given a Hold rating and two have issued a Sell rating to the company. According to data from MarketBeat, Bruker has a consensus rating of &#34;Hold&#34; and an average target price of $52.86.</p>
<div class="lb-trans"><p>布魯克的股票曾受到多份研究報告的關注。TD Cowen 在 11 月 4 日的報告中將布魯克的目標價格從 40.00 美元上調至 42.00 美元，並給予該股票 &#34;持有&#34; 評級。摩根大通在週一將布魯克的目標價格從 50.00 美元上調至 55.00 美元，並給予該股票 &#34;增持&#34; 評級。高盛集團在 12 月 9 日的研究報告中開始覆蓋布魯克股票，設定了 &#34;賣出&#34; 評級和 40.00 美元的目標價格。Redburn Partners 在 11 月 20 日的研究報告中設定了布魯克的目標價格為 60.00 美元。最後，瑞銀集團在 11 月 4 日的研究報告中將布魯克的目標價格從 40.00 美元上調至 43.00 美元，並給予該公司 &#34;中性&#34; 評級。一位股票研究分析師給予該股票 &#34;強烈買入&#34; 評級，八位分析師給予 &#34;買入&#34; 評級，六位分析師給予 &#34;持有&#34; 評級，二位分析師給予 &#34;賣出&#34; 評級。根據 MarketBeat 的數據，布魯克的共識評級為 &#34;持有&#34;，平均目標價格為 52.86 美元。</p>
</div><p><strong>Read Our Latest Stock Analysis on Bruker</strong></p>
<div class="lb-trans"><p><strong>閲讀我們關於布魯克的最新股票分析</strong></p>
</div><h2>Bruker Trading Up 1.2%</h2>
<div class="lb-trans"><h2>布魯克股票上漲 1.2%</h2>
</div><p>Shares of NASDAQ:BRKR opened at $45.67 on Tuesday. Bruker Corporation has a fifty-two week low of $28.53 and a fifty-two week high of $64.64. The company has a quick ratio of 0.91, a current ratio of 1.85 and a debt-to-equity ratio of 0.81. The company has a market cap of $6.94 billion, a PE ratio of -285.44, a P/E/G ratio of 6.64 and a beta of 1.17. The company's 50-day moving average price is $41.86 and its 200 day moving average price is $38.39.</p>
<div class="lb-trans"><p>NASDAQ:BRKR 的股票在週二開盤價為 45.67 美元。布魯克公司的 52 周低點為 28.53 美元，52 周高點為 64.64 美元。該公司的速動比率為 0.91，流動比率為 1.85，債務股本比率為 0.81。該公司的市值為 69.4 億美元，市盈率為 -285.44，市盈率/增長比率為 6.64，貝塔值為 1.17。該公司的 50 日移動平均價格為 41.86 美元，200 日移動平均價格為 38.39 美元。</p>
</div><p>Bruker (NASDAQ:BRKR - Get Free Report) last announced its quarterly earnings results on Monday, November 3rd. The medical research company reported $0.45 EPS for the quarter, beating the consensus estimate of $0.33 by $0.12. The company had revenue of $860.50 million for the quarter, compared to analyst estimates of $847.40 million. Bruker had a negative net margin of 0.61% and a positive return on equity of 15.45%. Bruker's revenue was down .5% compared to the same quarter last year. During the same quarter last year, the business earned $0.60 earnings per share. Bruker has set its FY 2025 guidance at 1.850-1.90 EPS. Sell-side analysts anticipate that Bruker Corporation will post 2.69 earnings per share for the current year.</p>
<div class="lb-trans"><p>布魯克（NASDAQ:BRKR - 獲取免費報告）最近在 11 月 3 日宣佈了其季度財報。該醫療研究公司報告的季度每股收益為 0.45 美元，超出市場共識預期的 0.33 美元，超出幅度為 0.12 美元。該季度的收入為 8.605 億美元，而分析師預期為 8.474 億美元。布魯克的淨利潤率為 -0.61%，股本回報率為 15.45%。與去年同期相比，布魯克的收入下降了 0.5%。去年同期，該公司每股收益為 0.60 美元。布魯克已將其 2025 財年的指導目標設定為 1.850-1.90 每股收益。賣方分析師預計布魯克公司今年的每股收益將達到 2.69 美元。</p>
</div><h2>Bruker Dividend Announcement</h2>
<div class="lb-trans"><h2>布魯克分紅公告</h2>
</div><p>The firm also recently declared a quarterly dividend, which will be paid on Friday, January 2nd. Shareholders of record on Monday, December 8th will be given a dividend of $0.05 per share. This represents a $0.20 dividend on an annualized basis and a yield of 0.4%. The ex-dividend date is Monday, December 8th. Bruker's payout ratio is -125.00%.</p>
<div class="lb-trans"><p>該公司最近還宣佈了一項季度分紅，將於 1 月 2 日（星期五）支付。12 月 8 日的股東將獲得每股 0.05 美元的分紅。這相當於每年 0.20 美元的分紅，收益率為 0.4%。除息日期為 12 月 8 日。布魯克的派息比率為 -125.00%。</p>
</div><h2>Insider Activity</h2>
<div class="lb-trans"><h2>內部交易活動</h2>
</div><p>In other news, Director John A. Ornell sold 6,233 shares of the firm's stock in a transaction on Thursday, November 6th. The stock was sold at an average price of $39.00, for a total transaction of $243,087.00. Following the transaction, the director directly owned 35,212 shares of the company's stock, valued at approximately $1,373,268. This trade represents a 15.04% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities &amp; Exchange Commission, which is accessible through the SEC website. Insiders own 27.30% of the company's stock.</p>
<div class="lb-trans"><p>在其他新聞中，董事 John A. Ornell 於 11 月 6 日在一筆交易中出售了 6,233 股該公司的股票。該股票以平均價格 39.00 美元出售，總交易額為 243,087.00 美元。交易後，該董事直接持有該公司 35,212 股股票，價值約 1,373,268 美元。這筆交易代表了其持股比例的 15.04% 的減少。該出售在向證券交易委員會提交的文件中披露，文件可通過 SEC 網站訪問。內部人士持有該公司 27.30% 的股票。</p>
</div><h2>Bruker Company Profile</h2>
<div class="lb-trans"><h2>布魯克公司簡介</h2>
</div><p>(Free Report)</p>
<div class="lb-trans"><p>（免費報告）</p>
</div><p>Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy &amp; Supercon Technologies.</p>
<div class="lb-trans"><p>布魯克公司及其子公司在美國、歐洲、亞太地區及國際上開發、製造和分銷科學儀器以及分析和診斷解決方案。該公司通過四個部門運營：布魯克科學儀器（BSI）生物旋轉、BSI CALID、BSI 納米和布魯克能源與超導技術。</p>
</div><h2>Featured Articles</h2>
<div class="lb-trans"><h2>特色文章</h2>
</div><ul>
<li>Five stocks we like better than Bruker</li>
<li>Best of the list of Dividend Aristocrats: Build wealth with the aristocrat index</li>
<li>ServiceNow’s $7 Billion Gamble: Panic or Opportunity?</li>
<li>What is a Dividend Harvesting Strategy and How Can Investors Profit from it?</li>
<li>Dell and HP Are Raising Prices—And Investors Should Take Note</li>
<li>Do Real Estate Investment Trusts Deserve a Place in Your Portfolio?</li>
<li>Why DLocal Is the Top Emerging Market Fintech Stock to Watch for 2026</li>
</ul>
<div class="lb-trans"><ul>
<li>五隻我們認為比布魯克更好的股票</li>
<li>最佳股息貴族名單：通過貴族指數積累財富</li>
<li>ServiceNow 的 70 億美元賭注：恐慌還是機會？</li>
<li>什麼是股息收割策略，投資者如何從中獲利？</li>
<li>戴爾和惠普正在提價——投資者應該注意</li>
<li>房地產投資信託是否應在您的投資組合中佔有一席之地？</li>
<li>為什麼 DLocal 是 2026 年值得關注的頂級新興市場金融科技股票</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9QlJLUg" alt="" original-src="https://www.marketbeat.com/scripts/SECFilingChart.ashx?Prefix=NASDAQ&amp;Symbol=BRKR"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即時新聞提醒由敍事科學技術和 MarketBeat 的金融數據生成，旨在為讀者提供最快的報道和公正的覆蓋。請將任何問題或意見發送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Bruker Right Now?</h2>
<div class="lb-trans"><h2>您現在應該投資 1,000 美元在布魯克嗎？</h2>
</div><p>Before you consider Bruker, you'll want to hear this.</p>
<div class="lb-trans"><p>在您考慮布魯克之前，您需要聽聽這個。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Bruker wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已識別出五隻頂級分析師悄悄向客户推薦的股票，建議在更廣泛的市場注意到之前購買……而布魯克並不在名單上。</p>
</div><p>While Bruker currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>雖然布魯克目前在分析師中被評為持有評級，但頂級分析師認為這五隻股票更值得購買。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在這裏查看這五隻股票</p>
</div>

Squarepoint Ops LLC 出售了布魯克公司 $BRKR 的股票